IRADIMED CORPORATION
DE ˙ DB ˙ US46266A1097
77,50 € ↑1,00 (1,31%)
2026-06-04
AKTIENPREIS
SecurityDE:46K / IRADIMED CORPORATION
InstitutionNorthern Trust Corp
Latest Disclosed Ownership123,636 shares
Latest Disclosed Value $ 11,901,201
Northern Trust Corp reports 6.37% decrease in ownership of 46K / IRADIMED CORPORATION

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 123,636 shares of IRADIMED CORPORATION (DE:46K) valued at $10,076,334 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 132,045 shares of IRADIMED CORPORATION. This represents a change in shares of -6.37% during the quarter. The current value of the position is $9,581,790 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F IRADIMED COM 46266A109 123,636 -8,409 -6.37 11,901 -7.35 0.0003
2026-02-17 2025-12-31 13F IRADIMED COM 46266A109 132,045 -5,454 -3.97 12,845 31.29 0.0003
2025-11-14 2025-09-30 13F IRADIMED COM 46266A109 137,499 -5,729 -4.00 9,784 14.26 0.0013
2025-08-13 2025-06-30 13F IRADIMED COM 46266A109 143,228 -16,132 -10.12 8,564 2.39 0.0012
2025-05-13 2025-03-31 13F IRADIMED COM 46266A109 159,360 16,291 11.39 8,363 6.29 0.0012
2025-02-14 2024-12-31 13F IRADIMED COM 46266A109 143,069 9,722 7.29 7,869 17.33 0.0011
2024-11-13 2024-09-30 13F IRADIMED COM 46266A109 133,347 7,461 5.93 6,706 21.24 0.0011
2024-08-14 2024-06-30 13F IRADIMED COM 46266A109 125,886 1,256 1.01 5,531 0.89 0.0009
2024-05-14 2024-03-31 13F IRADIMED COM 46266A109 124,630 39,026 45.59 5,482 34.92 0.0009
2024-02-13 2023-12-31 13F IRADIMED COM 46266A109 85,604 2,101 2.52 4,064 9.66 0.0007
2023-11-13 2023-09-30 13F IRADIMED COM 46266A109 83,503 3,830 4.81 3,705 -2.58 0.0007
2023-08-11 2023-06-30 13F IRADIMED COM 46266A109 79,673 995 1.26 3,804 22.88 0.0007
2023-05-15 2023-03-31 13F IRADIMED COM 46266A109 78,678 608 0.78 3,096 40.17 0.0006
2023-02-13 2022-12-31 13F IRADIMED COM 46266A109 78,070 367 0.47 2,209 -5.48 0.0005
2022-11-14 2022-09-30 13F IRADIMED COM 46266A109 77,703 -162 -0.21 2,336 -11.62 0.0005
2022-08-12 2022-06-30 13F IRADIMED COM 46266A109 77,865 3,855 5.21 2,643 -20.37 0.0006
2022-05-13 2022-03-31 13F IRADIMED COM 46266A109 74,010 -2,865 -3.73 3,319 -6.56 0.0006
2022-02-08 2021-12-31 13F IRADIMED COM 46266A109 76,875 -2,847 -3.57 3,552 32.64 0.0006
2021-11-15 2021-09-30 13F IRADIMED COM 46266A109 79,722 -188 -0.24 2,678 13.96 0.0005
2021-08-13 2021-06-30 13F IRADIMED COM 46266A109 79,910 -1,994 -2.43 2,350 11.32 0.0004
2021-05-12 2021-03-31 13F IRADIMED COM 46266A109 81,904 -17,256 -17.40 2,111 -6.59 0.0004
2021-02-11 2020-12-31 13F IRADIMED COM 46266A109 99,160 -6,249 -5.93 2,260 0.31 0.0004
2020-11-16 2020-09-30 13F IRADIMED COM 46266A109 105,409 -2,276 -2.11 2,253 -9.84 0.0005
2020-08-14 2020-06-30 13F IRADIMED COM 46266A109 107,685 10,710 11.04 2,499 20.67 0.0006
2020-05-14 2020-03-31 13F IRADIMED COM 46266A109 96,975 7,675 8.59 2,071 -0.77 0.0006
2020-02-14 2019-12-31 13F IRADIMED COM 46266A109 89,300 282 0.32 2,087 11.49 0.0005
2019-11-13 2019-09-30 13F IRADIMED COM 46266A109 89,018 15,722 21.45 1,872 24.88 0.0004
2019-08-13 2019-06-30 13F IRADIMED COM 46266A109 73,296 1,765 2.47 1,499 -25.42 0.0004
2019-05-13 2019-03-31 13F IRADIMED COM 46266A109 71,531 417 0.59 2,010 15.52 0.0005
2019-02-12 2018-12-31 13F IRADIMED COM 46266A109 71,114 -454 -0.63 1,740 -34.56 0.0005
2018-11-14 2018-09-30 13F IRADIMED COM 46266A109 71,568 12,791 21.76 2,659 118.13 0.0007
2018-09-18 2018-06-30 13F/A-1 IRADIMED COM 46266A109 58,777 31,986 119.39 1,219 215.80 0.0003
2018-08-14 2018-06-30 13F IRADIMED COM 46266A109 58,777 31,986 1,219
2018-05-09 2018-03-31 13F IRADIMED COM 46266A109 26,791 5,850 27.94 386 21.38 0.0001
2018-02-14 2017-12-31 13F IRADIMED COM 46266A109 20,941 44 0.21 318 58.21 0.0001
2017-11-13 2017-09-30 13F IRADIMED COM 46266A109 20,897 -210 -0.99 201 11.05 0.0001
2017-08-11 2017-06-30 13F IRADIMED COM 46266A109 21,107 -35,410 -62.65 181 -64.02 0.0001
2017-05-12 2017-03-31 13F IRADIMED COM 46266A109 56,517 -12,365 -17.95 503 -34.25 0.0001
2017-02-13 2016-12-31 13F IRADIMED COM 46266A109 68,882 4,330 6.71 765 -30.26 0.0002
2016-11-09 2016-09-30 13F IRADIMED COM 46266A109 64,552 -1,911 -2.88 1,097 -24.19 0.0003
2016-08-12 2016-06-30 13F IRADIMED COM 46266A109 66,463 22,932 52.68 1,447 73.50 0.0005
2016-08-19 2016-03-31 13F/A-1 IRADIMED COM 46266A109 43,531 1,675 4.00 834 -28.90 0.0003
2016-05-13 2016-03-31 13F IRADIMED COM 46266A109 43,531 834
2016-02-12 2015-12-31 13F IRADIMED COM 46266A109 41,856 12,516 42.66 1,173 64.06 0.0004
2015-11-12 2015-09-30 13F IRADIMED COM 46266A109 29,340 29,340 715 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.